Form 4: Cognition Therapeutics Chief Medical Officer Reports Tax-Related Stock Disposal
SEC Form 4 Filing
Anthony Caggiano, Chief Medical Officer of Cognition Therapeutics, reports the disposal of shares to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On February 15, 2025, Anthony Caggiano, the Chief Medical Officer of Cognition Therapeutics Inc. (CGTX), disposed of 5,296 shares of common stock to cover tax withholding obligations.
- The shares were disposed of at a price of $0.5901 per share.
- Following the transaction, Caggiano directly owns 418,554 shares of Cognition Therapeutics Inc.
Sentiment
Score: 5
Explanation: This is a neutral transaction related to tax obligations, not indicative of the company's overall performance or future prospects.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and directors. This transaction is related to tax obligations, which is a common occurrence.
Key Dates
| Date | Description |
|---|---|
| 02/15/2025 | Date of transaction: Disposal of shares to cover tax withholding obligations. |
| 02/18/2025 | Date of signature by Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.